{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:27:20Z","timestamp":1784917640408,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T00:00:00Z","timestamp":1301011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s11010-011-0793-6","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T19:37:24Z","timestamp":1300995444000},"page":"251-257","source":"Crossref","is-referenced-by-count":45,"title":["Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome"],"prefix":"10.1007","volume":"353","author":[{"given":"Val\u00e9ria A.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Jacob-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa A.","family":"Belo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo M.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna B. F.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui A.","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,25]]},"reference":[{"issue":"6","key":"793_CR1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.84.6.1897","volume":"84","author":"E Carmina","year":"1999","unstructured":"Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897\u20131899","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"793_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Group. TREA-SPCW","year":"2004","unstructured":"Group. TREA-SPCW (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325","journal-title":"Fertil Steril"},{"issue":"4","key":"793_CR3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929\u20131935","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"793_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84(1):165\u2013169","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"793_CR5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00001703-200106000-00013","volume":"13","author":"RJ Norman","year":"2001","unstructured":"Norman RJ (2001) Obesity, polycystic ovary syndrome and anovulation\u2013how are they interrelated? Curr Opin Obstet Gynecol 13(3):323\u2013327","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"793_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","volume":"66","author":"RJ Norman","year":"1996","unstructured":"Norman RJ, Masters S, Hague W (1996) Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril 66(6):942\u2013947","journal-title":"Fertil Steril"},{"issue":"10","key":"793_CR7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","volume":"36","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D (2006) Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 36(10):691\u2013697","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"793_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","volume":"93","author":"D Heutling","year":"2008","unstructured":"Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Krzyzanowska K, Randeva H, Schernthaner G, Lehnert H (2008) Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab 93(1):82\u201390","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"793_CR9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","volume":"58","author":"F Gonzalez","year":"2009","unstructured":"Gonzalez F, Rote NS, Minium J, Kirwan JP (2009) Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism 58(7):954\u2013962","journal-title":"Metabolism"},{"issue":"9","key":"793_CR10","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","volume":"20","author":"B Vural","year":"2005","unstructured":"Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A (2005) Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 20(9):2409\u20132413","journal-title":"Hum Reprod"},{"issue":"9","key":"793_CR11","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","volume":"89","author":"F Orio Jr","year":"2004","unstructured":"Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G, Colao A (2004) Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89(9):4588\u20134593","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"793_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000020681.19400.8A","volume":"106","author":"K Lakhani","year":"2002","unstructured":"Lakhani K, Seifalian AM, Hardiman P (2002) Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106(1):81\u201385","journal-title":"Circulation"},{"issue":"3","key":"793_CR13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2265.2008.03506.x","volume":"71","author":"GM Soares","year":"2009","unstructured":"Soares GM, Vieira CS, Martins WP, Franceschini SA, dos Reis RM, Silva de Sa MF, Ferriani RA (2009) Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome? Clin Endocrinol (Oxf) 71(3):406\u2013411","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"793_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.surg.2004.10.011","volume":"137","author":"P Sapienza","year":"2005","unstructured":"Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Cresti S, Cavallaro A (2005) Metalloproteinases and their inhibitors are markers of plaque instability. Surgery 137(3):355\u2013363","journal-title":"Surgery"},{"issue":"11","key":"793_CR15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.ATV.18.11.1707","volume":"18","author":"JL Johnson","year":"1998","unstructured":"Johnson JL, Jackson CL, Angelini GD, George SJ (1998) Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18(11):1707\u20131715","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"793_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.0000104013.71118.53","volume":"24","author":"M Formato","year":"2004","unstructured":"Formato M, Farina M, Spirito R, Maggioni M, Guarino A, Cherchi GM, Biglioli P, Edelstein C, Scanu AM (2004) Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries. Arterioscler Thromb Vasc Biol 24(1):129\u2013135","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"793_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107(12):1579\u20131585","journal-title":"Circulation"},{"issue":"3","key":"793_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hh1501.094396","volume":"89","author":"EE Creemers","year":"2001","unstructured":"Creemers EE, Cleutjens JP, Smits JF, Daemen MJ, van den Borne SW, Hanemaaijer R, Blankesteijn WM (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Circ Res 89(3):201\u2013210","journal-title":"Circ Res"},{"issue":"3","key":"793_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000087197","volume":"20","author":"M Fatar","year":"2005","unstructured":"Fatar M, Stroick M, Griebe M, Hennerici M, Creemers EE, Cleutjens JP, Smits JF, Daemen MJ, van den Borne SW, Hanemaaijer R, Blankesteijn WM (2005) Matrix metalloproteinases in cerebrovascular diseases Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cerebrovasc Dis 20(3):141\u2013151","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"793_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carpath.2007.12.012","volume":"18","author":"SW Borne van den","year":"2009","unstructured":"van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, Daemen MJ, Blankesteijn WM (2009) Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 18(1):37\u201343","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"793_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.CIR.0000135588.65188.14","volume":"110","author":"KJ Molloy","year":"2004","unstructured":"Molloy KJ, Thompson MM, Jones JL, Schwalbe EC, Bell PR, Naylor AR, Loftus IM (2004) Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 110(3):337\u2013343","journal-title":"Circulation"},{"issue":"12","key":"793_CR22","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/ATVBAHA.107.154831","volume":"27","author":"AM Tuomainen","year":"2007","unstructured":"Tuomainen AM, Nyyssonen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ (2007) Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 27(12):2722\u20132728","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"793_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCRESAHA.109.200279","volume":"105","author":"RC Laxton","year":"2009","unstructured":"Laxton RC, Hu Y, Duchene J, Zhang F, Zhang Z, Leung KY, Xiao Q, Scotland RS, Hodgkinson CP, Smith K, Willeit J, Lopez-Otin C, Simpson IA, Kiechl S, Ahluwalia A, Xu Q, Ye S (2009) A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res 105(9):921\u2013929","journal-title":"Circ Res"},{"issue":"1\u20132","key":"793_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2009.02.013","volume":"403","author":"FM Goncalves","year":"2009","unstructured":"Goncalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE (2009) Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clin Chim Acta 403(1\u20132):173\u2013177","journal-title":"Clin Chim Acta"},{"issue":"10\u201311","key":"793_CR25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.clinbiochem.2009.03.025","volume":"42","author":"VA Belo","year":"2009","unstructured":"Belo VA, Souza-Costa DC, Lana CM, Caputo FL, Marcaccini AM, Gerlach RF, Bastos MG, Tanus-Santos JE (2009) Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Clin Biochem 42(10\u201311):984\u2013990","journal-title":"Clin Biochem"},{"issue":"10\u201311","key":"793_CR26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.clinbiochem.2008.04.015","volume":"41","author":"AC Palei","year":"2008","unstructured":"Palei AC, Sandrim VC, Cavalli RC, Tanus-Santos JE (2008) Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem 41(10\u201311):875\u2013880","journal-title":"Clin Biochem"},{"issue":"5","key":"793_CR27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09513590802056995","volume":"24","author":"B Liu","year":"2008","unstructured":"Liu B, Cai LY, Lv HM, Xia L, Zhang YJ, Zhang HX, Guan YM (2008) Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol 24(5):285\u2013288","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"793_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-07-0822","volume":"158","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Margeli A, Papassotiriou I (2008) Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism? Eur J Endocrinol 158(4):525\u2013531","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"793_CR29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jc.2005-0648","volume":"91","author":"KC Lewandowski","year":"2006","unstructured":"Lewandowski KC, Komorowski J, O\u2019Callaghan CJ, Tan BK, Chen J, Prelevic GM, Randeva HS (2006) Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):1173\u20131177","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"793_CR30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","volume":"75","author":"JD Raffetto","year":"2008","unstructured":"Raffetto JD, Khalil RA (2008) Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75(2):346\u2013359","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"793_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347","journal-title":"Hum Reprod"},{"issue":"6","key":"793_CR32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"1","key":"793_CR33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0015-0282(16)45254-4","volume":"35","author":"RS Mathur","year":"1981","unstructured":"Mathur RS, Moody LO, Landgrebe S, Williamson HO (1981) Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril 35(1):29\u201335","journal-title":"Fertil Steril"},{"issue":"7","key":"793_CR34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419","journal-title":"Diabetologia"},{"issue":"5","key":"793_CR35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clinbiochem.2005.02.010","volume":"38","author":"CD Souza-Tarla","year":"2005","unstructured":"Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE (2005) Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 38(5):410\u2013414","journal-title":"Clin Biochem"},{"issue":"1","key":"793_CR36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ab.2005.04.038","volume":"344","author":"RF Gerlach","year":"2005","unstructured":"Gerlach RF, Uzuelli JA, Souza-Tarla CD, Tanus-Santos JE (2005) Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 344(1):147\u2013149","journal-title":"Anal Biochem"},{"issue":"1\u20132","key":"793_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2006.10.007","volume":"40","author":"RF Gerlach","year":"2007","unstructured":"Gerlach RF, Demacq C, Jung K, Tanus-Santos JE (2007) Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem 40(1\u20132):119\u2013123","journal-title":"Clin Biochem"},{"issue":"Pt 3","key":"793_CR38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1042\/bj20021573","volume":"372","author":"JR Worley","year":"2003","unstructured":"Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knauper V (2003) Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Biochem J 372(Pt 3):799\u2013809","journal-title":"Biochem J"},{"issue":"Pt 2","key":"793_CR39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3310453","volume":"331","author":"S Cowell","year":"1998","unstructured":"Cowell S, Knauper V, Stewart ML, D\u2019Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G (1998) Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 331(Pt 2):453\u2013458","journal-title":"Biochem J"},{"issue":"9588","key":"793_CR40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370(9588):685\u2013697","journal-title":"Lancet"},{"issue":"5","key":"793_CR41","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","volume":"90","author":"E Carmina","year":"2005","unstructured":"Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA, Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545\u20132549","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"793_CR42","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","volume":"22","author":"M Luque-Ramirez","year":"2007","unstructured":"Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF (2007) Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum Reprod 22(12):3197\u20133203","journal-title":"Hum Reprod"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0793-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-0793-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0793-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T15:05:30Z","timestamp":1592406330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-0793-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,25]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-0793-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,25]]}}}